Freitas, S., Martins, R., Costa, M., Leão, P. N., et al. (2016). Hierridin B Isolated from a Marine Cyanobacterium Alters VDAC1, Mitochondrial Activity, and Cell Cycle Genes on HT-29 Colon Adenocarcinoma Cells. Marine Drugs, 14(9).

Freitas, S., Martins, R., Campos, A., Azevedo, J., et al. (2016). Insights into the potential of picoplanktonic marine cyanobacteria strains for cancer therapies - Cytotoxic mechanisms against the RKO colon cancer cell line. Toxicon, 119, 140 - 151.

Pereira, C. L., Teixeira, G. Q., Ribeiro-Machado, C., Caldeira, J., et al. (2016). Mesenchymal Stem/Stromal Cells seeded on cartilaginous endplates promote Intervertebral Disc Regeneration through Extracellular Matrix Remodeling. Scientific Reports, 6.

Costa, M., Cruz, E., Oliveira, S., Benes, V., et al. (2015). Lymphocyte gene expression signatures from patients and mouse models of hereditary hemochromatosis reveal a function of hfe as a negative regulator of cd8+ t-Lymphocyte activation and differentiation in vivo. PLoS ONE, 10(4).

Leão, P. N., Costa, M., Ramos, V., Pereira, A. R., et al. (2013). Antitumor Activity of Hierridin B, a Cyanobacterial Secondary Metabolite Found in both Filamentous and Unicellular Marine Strains. PLoS ONE, 8(7).

Costa, M., Costa-Rodrigues, J., Fernandes, M. H., Barros, P., et al. (2012). Marine cyanobacteria compounds with anticancer properties: A review on the implication of apoptosis. Marine Drugs, 10(10), 2181 - 2207.

Pellegrino, R. M., Coutinho, M., D'Ascola, D., Lopes, A. M., et al. (2012). Two novel mutations in the tmprss6 gene associated with iron-refractory iron-deficiency anaemia (irida) and partial expression in the heterozygous form. British Journal of Haematology, 158(5), 668 - 672.

MacEdo, M. F., Porto, G., Costa, M., Vieira, C. P., et al. (2010). Low numbers of CD8 + T lymphocytes in hereditary haemochromatosis are explained by a decrease of the most mature CD8 + effector memory T cells. Clinical and Experimental Immunology, 159(3), 363 - 371.